Liselotte Öhberg

Title: Liselotte Öhberg: Innovator in Cognitive Health

Introduction

Liselotte Öhberg is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of cognitive health through her innovative research and development of pharmaceutical compounds. With a total of 2 patents, her work focuses on addressing critical health issues related to cognitive impairment and neurodegeneration.

Latest Patents

Öhberg's latest patents include groundbreaking inventions aimed at treating and preventing various Aβ-related pathologies. One of her notable patents involves compounds that serve as BACE inhibitors, which are crucial in the treatment of conditions such as Alzheimer's disease and other cognitive disorders. These compounds are designed to provide therapeutic methods for a range of cognitive impairments, including mild cognitive impairment, memory loss, and neurodegeneration associated with diseases like dementia.

Career Highlights

Throughout her career, Liselotte Öhberg has worked with leading pharmaceutical companies, including AstraZeneca AB and Astex Therapeutics Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cognitive health treatments.

Collaborations

Öhberg has collaborated with several professionals in her field, including Annika Kers and Karin Kolmodin. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her research and development efforts.

Conclusion

Liselotte Öhberg's contributions to the field of cognitive health through her patents and collaborations highlight her dedication to improving the lives of individuals affected by cognitive disorders. Her innovative work continues to pave the way for new therapeutic approaches in the treatment of Alzheimer's disease and related conditions.